Khosla Ventures Acquisition (KVSA): Price and Financial Metrics Recent IPO


Khosla Ventures Acquisition (KVSA): $9.91

0.01 (+0.10%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

KVSA Stock Price Chart Interactive Chart >

Price chart for KVSA

KVSA Price/Volume Stats

Current price $9.91 52-week high $10.97
Prev. close $9.90 52-week low $9.86
Day low $9.87 Volume 140,900
Day high $9.93 Avg. volume 369,663
50-day MA $10.21 Dividend yield N/A
200-day MA $0.00 Market Cap 351.71M

Khosla Ventures Acquisition (KVSA) Company Bio


Khosla Ventures Acquisition is a newly incorporated blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities.


KVSA Latest News Stream


Event/Time News Detail
Loading, please wait...

KVSA Latest Social Stream


Loading social stream, please wait...

View Full KVSA Social Stream

Latest KVSA News From Around the Web

Below are the latest news stories about Khosla Ventures Acquisition Co that investors may wish to consider to help them evaluate KVSA as an investment opportunity.

Moore Kuehn Encourages KVSA, VPCC, KURI, and ANY Investors to Contact Law Firm

NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: Khosla Ventures Acquisition Co. (NASDAQ: KVSA) Kholsa Ventures has agreed to merge with Valo Hea

Yahoo | June 11, 2021

Valo Health To Combine With Vinod Khosla-Backed SPAC In $2.8B Deal

Boston-based Valo Health LLC has agreed to go public through a reverse merger with a blank-check firm backed by venture capitalist Vinod Khosla, in a deal valuing the combined company at about $2.8 billion. Founded in 2019, Valo Health is a biotech company that uses data analysis and artificial intelligence to help drug discovery and development. Valo Health’s platform Opal has a pipeline of candidates across cardiovascular disease, oncology, and neurodegeneration. Its deal with Khosla Ventures

Yahoo | June 9, 2021

Valo Health and Khosla Ventures Acquisition Co. to Combine and Create Publicly Traded Company Focused on Transforming the Drug Discovery and Development Process

Valo Health, LLC ("Valo"), the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process, and Khosla Ventures Acquisition Co. ("KVAC") (NASDAQ: KVSA), a special purpose acquisition company founded by affiliates of Khosla Ventures, LLC, announced today that they have entered into a definitive merger agreement.

Yahoo | June 9, 2021

Read More 'KVSA' Stories Here

KVSA Price Returns

1-mo -1.00%
3-mo -3.79%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6741 seconds.